Back
Travere Therapeutics Vs. Neurogene Industry Stock Comparison
Sell
45
TVTX
Travere Therapeutics
Last Price:
13.5100
Seasonality Move:
-12.44%
Sell
48
NGNE
Neurogene
Last Price:
42.13
Seasonality Move:
-0.92%
Sell
45
Travere Therapeutics (TVTX)
is a Sell
Is Travere Therapeutics a Buy, Sell or Hold?
- The current Travere Therapeutics [TVTX] share price is $13.4800. The Score for TVTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- TVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $41.95. The Score for NGNE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TVTX Stock Price Chart
What is Travere Therapeutics's stock price today?
-
The Travere Therapeutics share price today is $13.4800
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NGNE Stock Price Chart
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.02 | Buy |
| Relative Strength Index (14 RSI): | 79.38 | Buy |
| Chaikin Money Flow: | 1900513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.3004 - 11.4404) | Buy |
| Bollinger Bands (100): | (6.5341 - 9.9941) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 64.64 | Buy |
| Chaikin Money Flow: | -48 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.85 - 38.01) | Buy |
| Bollinger Bands (100): | (32.46 - 40.24) | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.87 | Buy |
| 20-day SMA: | 10.17 | Buy |
| 50-day SMA: | 9.65 | Buy |
| 200-day SMA: | 8.17 | Buy |
| 8-day EMA: | 12.01 | Buy |
| 20-day EMA: | 10.75 | Buy |
| 50-day EMA: | 9.66 | Buy |
| 200-day EMA: | 9.2 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.31 | Buy |
| 20-day SMA: | 36.23 | Buy |
| 50-day SMA: | 38.31 | Buy |
| 200-day SMA: | 33.13 | Buy |
| 8-day EMA: | 38.37 | Buy |
| 20-day EMA: | 37.13 | Buy |
| 50-day EMA: | 37.13 | Buy |
| 200-day EMA: | 32.93 | Buy |
Travere Therapeutics Earnings Growth & TVTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.36 per share, a decrease this year of $2.18 per share, and an increase next year of $2.31 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Travere Therapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||